articleCOVID-19: the big repurpose and even bigger pharmaceutical partnership14 May 2020 | By Heidi West (Vohra Wound Physicians)Heidi West discusses how academia, government and the pharmaceutical industry can work together to potentially repurpose drugs for the treatment of COVID-19.
newsMRC and LifeArc announce grants for Gene Therapy Innovation Hubs in UK7 May 2020 | By Victoria Rees (European Pharmaceutical Review)The UK MRC and LifeArc are making £16 million available as grants to fund the establishment of Gene Therapy Innovation Hubs to improve resources for researchers and manufacturers.
newsResearchers design first new polio vaccine in 50 years28 April 2020 | By Victoria Rees (European Pharmaceutical Review)A polio vaccine designed to be incapable of evolving the ability to cause disease in humans has shown promise in a Phase I clinical trial.
articleEmerging biotechs tackle medical research continuity concerns amid COVID-1924 April 2020 | By Rich Horgan (Founder and President of Cure Rare Disease)While medical professionals fight COVID-19 on the front line, small biotech businesses face a new uphill battle – maintaining research continuity for non-COVID-19 life-changing therapeutics.
newsCOVID-19 Clinical Research Coalition to accelerate coronavirus R&D in resource-poor countries6 April 2020 | By Hannah Balfour (European Pharmaceutical Review)The coalition has been formed to find R&D solutions for low- and middle-income countries to limit the impact of the COVID-19 pandemic in areas with fragile healthcare systems.
newsEMA offers free advice to COVID-19 vaccine and therapeutic developers16 March 2020 | By Hannah Balfour (European Pharmaceutical Review)The European Medicines Agency (EMA) announced it will provide free advice to those working on COVID-19 therapeutics and vaccines in the hopes of accelerating approval of a treatment.
newsFlow cytometry market expected to reach $6.36 billion by 202712 March 2020 | By Hannah Balfour (European Pharmaceutical Review)New research suggests the flow cytometry sector will grow at a CAGR of 8.2 percent due to increased adoption and expanding uses.
newsGlobal CRO market to reach $71.7 billion by 2024, says research6 February 2020 | By Hannah Balfour (European Pharmaceutical Review)A report suggests the need for novel therapies and cost-effective R&D will drive growth for contract research organisations, especially in Asia-Pacific.
newsCoronavirus: EMA announces support for treatment research6 February 2020 | By Victoria Rees (European Pharmaceutical Review)The EMA has released a statement on its efforts to support the development of a treatment for the novel coronavirus (2019-nCoV).
newsUK government pledges £20m to CEPI for coronavirus vaccine research4 February 2020 | By Hannah Balfour (European Pharmaceutical Review)The UK Health Secretary announced the government will give Coalition for Epidemic Preparedness Innovations (CEPI) £20 million to research vaccines for the 2019 novel coronavirus (2019-nCoV).
newsJohnson & Johnson launch response to Coronavirus3 February 2020 | By Hannah Balfour (European Pharmaceutical Review)Johnson & Johnson announced Janssen Pharmaceutical Companies will work collaboratively to screen for antiviral therapies and vaccine therapies against 2019-nCoV.
newsProtein engineering market predicted to be worth $3.9 billion by 202429 January 2020 | By Hannah Balfour (European Pharmaceutical Review)A report on the protein engineering market suggests it will grow at a CAGR of 12.4 percent, primarily due to protein-based drugs and pharmaceutical company development.
newsFunding for AI in drug development, clinical trials and information synthesis hits $5.2bn7 January 2020 | By Hannah Balfour (European Pharmaceutical Review)A study has suggested that while funding for artificial intelligence in pharma was $5.2bn in 2019, overall investment is slowing.
newsAstellas enters into definitive agreement to acquire Audentes Therapeutics4 December 2019 | By Rachael Harper (European Pharmaceutical Review)Astellas has announced that it will be acquiring Audentes Therapeutics at a total cost of $3 billion.
newsSir Peter Ratcliffe awarded joint Nobel Prize for Physiology or Medicine8 October 2019 | By Victoria Rees (European Pharmaceutical Review)The researcher Sir Peter Ratcliffe and two others have been jointly awarded the Nobel Prize for Physiology or Medicine 2019.
